Original Broadcast: Morning Money at 6:00
Just five weeks ago, shares in Sareum Holdings rocketed over 150% after it announced its cancer drug candidate had been licensed to Nasdaq listed ProNAi Therapeutics. The company discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases and its results are out. Dr Tim Mitchell is the CEO and he joined Share Radio to discuss the numbers.
Guests: Chris Bailey,Dr Tim Mitchell
Published:
Original Broadcast: Morning Money at 6:00
Last week it emerged that Tata Steel was considering keeping its UK steelmaking arm, after putting the loss-making business up for sale in March. The development has raised further hopes that the Port Talbot plant can be saved and David Blackaby, Professor of Economics at Swansea University, looked at why a U-turn is being considered.
Guests: Chris Bailey,David Blackaby
Published:
